Translation Manchester are excited to announce the return of our popular monthly webinar series ‘Gateway to Translation (G2T)’, after a break over summer.
The “Gateway to Translation” (G2T) webinar series is a joint initiative between the University of Cambridge (Cambridge Academy of Therapeutic Sciences, CATS) and The University of Manchester (Translation Manchester).
The aim of these monthly webinars is to stimulate the translation of research into the clinics by educating academics about trends, technologies and research in the commercial sphere and by facilitating collaborations between academia and the medtech, biotech and pharma industry sectors.
Our September webinar features Dr Jasper Van Hoorick — Chemist, Innovator & CEO of BIO INX — a pioneering biotech startup revolutionising the world of 3D bioprinting.
Webinar Chair: Prof Athina Markaki — Professor of Materials and Biomedical Engineering, University of Cambridge
Register for your place at this event
Speaker Bio:
Jasper Van Hoorick is a Belgian chemist and innovator who leads BIO INX, a Ghent based biotech startup specializing in advanced bioinks for 3D bioprinting. He focused his PhD research on biodegradable polymers and multiphoton lithography for ocular tissue regeneration, for which he earned his doctorate summa cum laude from Ghent University and VUB for which he was awarded the Agoria (2014), Solvay (2019) and Julia Polak Awards (2020). He co-authored over 30 peer reviewed publications in the field of 3D bioprinting and has a H-index of 24 (google scholar). In 2022, he spun out BIO INX from the research group of professor Sandra Van Vlierberghe together with among others Aysu Arslan (CSO), drawing on their polymer chemistry expertise to develop high precision bioinks for tissue engineering and drug-testing applications.
Jasper’s ambition goes beyond replacing animal testing—he hopes to advance to bioprinting functional human tissues, even organs for space research and regenerative medicine. Under his leadership, BIO INX is now a global player in biofabrication materials, continuing to partner on cutting-edge research and commercialization of next-generation bioinks
Recordings from previous webinars are available on the Translation Manchester and CATS websites.
